Skip to main content

Table 3 Echocardiographic data in study population at baseline and post marathon (n = 25)

From: The impact of repeated marathon running on cardiovascular function in the aging population

Echo parameters

Baseline

Post-race

Follow-up

p-value

 LV parameters (2D TTE) 

LVEDD (mm)

50 ± 3

51 ± 5

50 ± 4

0.93

LVESD (mm)

33 ± 5

34 ± 4

32 ± 5

0.82

LVEDV (ml)

114 ± 12

110 ± 10

112 ± 11

0.72

LVESV (ml)

39 ± 11

38 ± 13

40 ± 11

0.77

IVS (mm)

9 ± 2

9 ± 1

9 ± 2

0.82

PWT (mm)

9 ± 1

8 ± 2

9 ± 2

0.71

LVEF (%)

63 ± 4

62 ± 6

64 ± 3

0.79

LV mass/BSA (g/m2)

102 ± 11

103 ± 15

99 ± 17

0.49

 LA parameters (2D TTE) 

LA diameter (mm)

36 ± 4

37 ± 3

36 ± 5

0.66

LA volume (ml)

42 ± 11

44 ± 13

40 ± 13

0.44

 RA and RV parameters (2D TTE) 

RA volume (ml)

37 ± 12

61 ± 12

31 ± 13

0.01*

RVEDD (mm)

27 ± 3

45 ± 2

32 ± 4

0.02*

RV FAC (%)

48 ± 3

29 ± 6

49 ± 4

0.01*

TAPSE (mm)

2.3 ± 0.4

1.4 ± 0.2

2.1 ± 0.3

0.02*

  1. Data are expressed as mean ± SD. *p < 0.05, after the race vs. baseline.
  2. 2D, 2 dimensional; TTE, transthoracic echocardiography; LVEDD, LV end-diastolic diameter; LVESD, LV end-systolic diameter; LVEDV, LV end-diastolic volume; LVESV, LV end-systolic volume; IVS, interventricular septum; PWT, posterior wall thickness; LVEF, LV ejection fraction; BSA, body surface area; LA, left atrium; RA, right atrium; RVEDD, RV end-diastolic diameter; FAC, fractional area change; TAPSE, tricuspid annular plane systolic excursion.